Here are @DocWang4 works from our lab as major contributor. Congratulations, and cannot wait to see you achieve more as a wonderful neurosurgeon as well as an amazing scientist. https://t.co/UDgC8TbdJN https://t.co/itP9qJtuuv https://t.co/IwOtSbGfRB
Looking forward to Rich Young's #ISM2022 Keynote talk on cellular regulation and new targets. Recently identified targetable regulators in #myeloma include KDM5A, found in study: https://t.co/0Qkhy5u3An. https://t.co/hPsLzZotgm
RT @BCD_AACR: #ICYMI: Lysine Demethylase 5A Is Required for MYC-Driven Transcription in #MultipleMyeloma. https://t.co/hcIHrFL0yo @JunQiLab…
#ICYMI: Lysine Demethylase 5A Is Required for MYC-Driven Transcription in #MultipleMyeloma. https://t.co/hcIHrFL0yo @JunQiLab https://t.co/OAVx0HMOIh
RT @JunQiLab: i will have this part of my discussion on my poster as well. Inhibitor or degrader? they are both important and useful for…
RT @JunQiLab: i will have this part of my discussion on my poster as well. Inhibitor or degrader? they are both important and useful for…
i will have this part of my discussion on my poster as well. Inhibitor or degrader? they are both important and useful for study the target protein mechanism in cancer. how to design them then? swing by my poster on Wednesday.
Recent studies on #epigenetics and gene regulation, the topic of #AACR22 Major Symposium: KDM5A enabling elongation of Myc-driven transcription in #myeloma. https://t.co/aaEO1JhRfu @JunQiLab https://t.co/Md4eZzwkmj
Your collaborations are important for us. We cannot wait to collaborate with you more.
RT @LauberthLab: Happy to have worked with @JunQiLab and others on this exciting study. Lysine Demethylase 5A is Required for MYC Driven Tr…
RT @_TanyaBondar_: Excited to see @JunQiLab article featured as @LLSusa Editor Choice! https://t.co/A3lU42mL8N The article is free to read…
Excited to see @JunQiLab article featured as @LLSusa Editor Choice! https://t.co/A3lU42mL8N The article is free to read on @BCD_AACR website: https://t.co/dDZVAKW5uV
RT @JunQiLab: We really appreciate @AACR journals that accepted and published our KDM5 story @BCD_AACR @_TanyaBondar_ and EP300 story @CD_…
Cool therapeutic strategy!
RT @JunQiLab: We really appreciate @AACR journals that accepted and published our KDM5 story @BCD_AACR @_TanyaBondar_ and EP300 story @CD_…
RT @JunQiLab: We really appreciate @AACR journals that accepted and published our KDM5 story @BCD_AACR @_TanyaBondar_ and EP300 story @CD_…
RT @JunQiLab: We really appreciate @AACR journals that accepted and published our KDM5 story @BCD_AACR @_TanyaBondar_ and EP300 story @CD_…
RT @JunQiLab: We really appreciate @AACR journals that accepted and published our KDM5 story @BCD_AACR @_TanyaBondar_ and EP300 story @CD_…
We really appreciate @AACR journals that accepted and published our KDM5 story @BCD_AACR @_TanyaBondar_ and EP300 story @CD_AACR https://t.co/VAGu97c3Q0 https://t.co/naRJ2BGvCG
RT @JunQiLab: yes, we are excited to share our chemical probe JQKD82 that can block KDM5 catalytic function in vitro and in vivo.
RT @JunQiLab: yes, we are excited to share our chemical probe JQKD82 that can block KDM5 catalytic function in vitro and in vivo.
RT @JunQiLab: yes, we are excited to share our chemical probe JQKD82 that can block KDM5 catalytic function in vitro and in vivo.
yes, we are excited to share our chemical probe JQKD82 that can block KDM5 catalytic function in vitro and in vivo.
#ICYMI: Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma. https://t.co/MIFdWUNqBm @JunQiLab @DanaFarberNews https://t.co/Y4EIS5raDI
RT @JunQiLab: We would love the further study the KDM5 inhibition in different diseases and cancers through collaborations. Our molecule J…
RT @JunQiLab: We would love the further study the KDM5 inhibition in different diseases and cancers through collaborations. Our molecule J…
RT @BCD_AACR: #ICYMI: Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple myeloma. https://t.co/sVYGxQeoNG @JunQiLab…
We would love the further study the KDM5 inhibition in different diseases and cancers through collaborations. Our molecule JQKD82 is a good in vitro and in vivo probe to study KDM5 function.
#ICYMI: Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple myeloma. https://t.co/sVYGxQeoNG @JunQiLab @DanaFarberNews https://t.co/SfZekijlat
Newly discovered epigenetic regulatory mechanisms involved in multiple myeloma growth https://t.co/4NvLlWtglU https://t.co/DRee0mfqrp https://t.co/1j6uEoHUhs
RT @BCD_AACR: #ICYMI: Lysine Demethylase 5A is Required for MYC Driven Transcription in #MultipleMyeloma. https://t.co/GbbqAd0ZRz @JunQiLab…
#ICYMI: Lysine Demethylase 5A is Required for MYC Driven Transcription in #MultipleMyeloma. https://t.co/GbbqAd0ZRz @JunQiLab @DanaFarberNews https://t.co/qIpIGDp5S4
RT @Myeloma_Doc: #Myeloma Paper of the Day: Lysine demethylase 5A is required for MYC driven transcription in multiple #myeloma: https://t.…
RT @Myeloma_Doc: #Myeloma Paper of the Day: Lysine demethylase 5A is required for MYC driven transcription in multiple #myeloma: https://t.…
#Myeloma Paper of the Day: Lysine demethylase 5A is required for MYC driven transcription in multiple #myeloma: https://t.co/7LZ8LQ4lnH. https://t.co/Rli8TVzXAj
RT @JunQiLab: it is great to see that our paper in Blood Cancer Discovery @BCD_AACR showed up in PubMed. https://t.co/kPTfWMdw40
RT @JunQiLab: it is great to see that our paper in Blood Cancer Discovery @BCD_AACR showed up in PubMed. https://t.co/kPTfWMdw40
RT @JunQiLab: here is our paper. thanks for all the collaborators, and @LLSResearch for the support.
RT @JunQiLab: here is our paper. thanks for all the collaborators, and @LLSResearch for the support.
New article: Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma https://t.co/bg2DkojZaJ #MMSM #MultipleMyeloma #hematology https://t.co/MQZebSGHak
here is our paper. thanks for all the collaborators, and @LLSResearch for the support.
From the July issue: Lysine Demethylase 5A is Required for MYC Driven Transcription in multiple myeloma. https://t.co/vOGyVWZdZH @JunQiLab @DanaFarberNews https://t.co/0e2HmjXG6p
RT @JunQiLab: it is great to see that our paper in Blood Cancer Discovery @BCD_AACR showed up in PubMed. https://t.co/kPTfWMdw40
RT @JunQiLab: it is great to see that our paper in Blood Cancer Discovery @BCD_AACR showed up in PubMed. https://t.co/kPTfWMdw40
it is great to see that our paper in Blood Cancer Discovery @BCD_AACR showed up in PubMed. https://t.co/kPTfWMdw40
New article: Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple Myeloma https://t.co/fWUYgPMdFJ #MMSM #MultipleMyeloma #hematology https://t.co/yaUyIlUb6e
RT @_TanyaBondar_: This @BCD_AACR article https://t.co/fSvFpcBg8j by @JunQiLab is in the news this week: New epigenetic regulatory mechan…
RT @_TanyaBondar_: This @BCD_AACR article https://t.co/fSvFpcBg8j by @JunQiLab is in the news this week: New epigenetic regulatory mechan…
RT @_TanyaBondar_: This @BCD_AACR article https://t.co/fSvFpcBg8j by @JunQiLab is in the news this week: New epigenetic regulatory mechan…
RT @_TanyaBondar_: This @BCD_AACR article https://t.co/fSvFpcBg8j by @JunQiLab is in the news this week: New epigenetic regulatory mechan…
RT @_TanyaBondar_: This @BCD_AACR article https://t.co/fSvFpcBg8j by @JunQiLab is in the news this week: New epigenetic regulatory mechan…
RT @JunQiLab: glad to see our story is in the news.
glad to see our story is in the news.
RT @_TanyaBondar_: This @BCD_AACR article https://t.co/fSvFpcBg8j by @JunQiLab is in the news this week: New epigenetic regulatory mechan…
This @BCD_AACR article https://t.co/fSvFpcBg8j by @JunQiLab is in the news this week: New epigenetic regulatory mechanisms involved in multiple myeloma growth: Expectations for the development of therapies targeting KDM5A https://t.co/FJYJeWKfcC https://
RT @BCD_AACR: Watching the #AACRMDT21 drug resistance session? Learn more about how KDM5A is a new target in Myc-driven #myeloma. https://t…
Watching the #AACRMDT21 drug resistance session? Learn more about how KDM5A is a new target in Myc-driven #myeloma. https://t.co/NeMUj6O9mZ https://t.co/jQ6vCitKnK
RT @BCD_AACR: Watching #AACRMDT21 #epigenetics session? Read a recent article on KDM5A dependence of Myc-driven #myeloma. #mmsm https://t.c…
RT @BCD_AACR: Watching #AACRMDT21 #epigenetics session? Read a recent article on KDM5A dependence of Myc-driven #myeloma. #mmsm https://t.c…
Watching #AACRMDT21 #epigenetics session? Read a recent article on KDM5A dependence of Myc-driven #myeloma. #mmsm https://t.co/J2EpSLiiIN https://t.co/PUDXERc2ux
RT @MilkaKostic: New paper from @JunQiLab that describes a cell-permeable and selective KDM5 inhibitor, JQKD82 and uses it to establish tha…
RT @LauberthLab: Happy to have worked with @JunQiLab and others on this exciting study. Lysine Demethylase 5A is Required for MYC Driven Tr…
RT @MilkaKostic: New paper from @JunQiLab that describes a cell-permeable and selective KDM5 inhibitor, JQKD82 and uses it to establish tha…
RT @IRDA_KU: 大口裕人准教授らの研究グループが多発性骨髄腫増殖の新規エピゲノム制御機構を発見！ "Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma"…
RT @IRDA_KU: 大口裕人准教授らの研究グループが多発性骨髄腫増殖の新規エピゲノム制御機構を発見！ "Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma"…
RT @MilkaKostic: New paper from @JunQiLab that describes a cell-permeable and selective KDM5 inhibitor, JQKD82 and uses it to establish tha…
RT @MilkaKostic: New paper from @JunQiLab that describes a cell-permeable and selective KDM5 inhibitor, JQKD82 and uses it to establish tha…
RT @MilkaKostic: New paper from @JunQiLab that describes a cell-permeable and selective KDM5 inhibitor, JQKD82 and uses it to establish tha…
RT @IRDA_KU: 大口裕人准教授らの研究グループが多発性骨髄腫増殖の新規エピゲノム制御機構を発見！ "Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma"…
大口裕人准教授らの研究グループが多発性骨髄腫増殖の新規エピゲノム制御機構を発見！ "Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma" https://t.co/Ixowq7rthG @BCD_AACR #Myeloma #IRDA #kumamotouniversity
RT @LauberthLab: Happy to have worked with @JunQiLab and others on this exciting study. Lysine Demethylase 5A is Required for MYC Driven Tr…
RT @LauberthLab: Happy to have worked with @JunQiLab and others on this exciting study. Lysine Demethylase 5A is Required for MYC Driven Tr…
RT @LauberthLab: Happy to have worked with @JunQiLab and others on this exciting study. Lysine Demethylase 5A is Required for MYC Driven Tr…
RT @LauberthLab: Happy to have worked with @JunQiLab and others on this exciting study. Lysine Demethylase 5A is Required for MYC Driven Tr…
Happy to have worked with @JunQiLab and others on this exciting study. Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma https://t.co/XsurudtzjK
New paper from @JunQiLab that describes a cell-permeable and selective KDM5 inhibitor, JQKD82 and uses it to establish that KDM5A supports MYC target gene transcription independent of MYC. Congrats to the team! https://t.co/CWIVQ0mnmr
RT @moreauxjerome: Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma https://t.co/qSozBXQjM1
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma https://t.co/qSozBXQjM1
here is the link for the paper: https://t.co/nDNHhgLaql
RT @FilipGarbicz: KDM5A supports MYC target gene transcription independent of MYC, by supporting TFIIH (CDK7)- and P-TEFb (CDK9)-mediated p…
RT @FilipGarbicz: KDM5A supports MYC target gene transcription independent of MYC, by supporting TFIIH (CDK7)- and P-TEFb (CDK9)-mediated p…
RT @JunQiLab: Here is the link to the paper. https://t.co/c7JEkhA9Kr
RT @FilipGarbicz: KDM5A supports MYC target gene transcription independent of MYC, by supporting TFIIH (CDK7)- and P-TEFb (CDK9)-mediated p…
RT @JunQiLab: It is so exciting that our KDM5 story in MM is online now. Congratulations to the team, and thanks to all the wonderful coll…
RT @JunQiLab: It is so exciting that our KDM5 story in MM is online now. Congratulations to the team, and thanks to all the wonderful coll…
RT @JunQiLab: Here is the link to the paper. https://t.co/c7JEkhA9Kr
RT @AuclairDan: Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple #Myeloma #mmsm https://t.co/toIG6WjiUP
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma https://t.co/0vdzY8iYIb
Here is the link to the paper. https://t.co/c7JEkhA9Kr
It is so exciting that our KDM5 story in MM is online now. Congratulations to the team, and thanks to all the wonderful collaborators. Anderson Lab, @ADurbinLab @GryderArt
RT @FilipGarbicz: KDM5A supports MYC target gene transcription independent of MYC, by supporting TFIIH (CDK7)- and P-TEFb (CDK9)-mediated p…
KDM5A supports MYC target gene transcription independent of MYC, by supporting TFIIH (CDK7)- and P-TEFb (CDK9)-mediated phosphorylation of RNAPII. KDM5A is a vulnerability in MM functioning through reg. of MYC-dep. transcription. JQKD82 = KDM5A inhibitor.
RT @AuclairDan: Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple #Myeloma #mmsm https://t.co/toIG6WjiUP
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple #Myeloma #mmsm https://t.co/toIG6WjiUP
Article opener art is based on Fig 6H, which illustrates how KDM5A binding to H3K4me3 can recruit cdk9 to phosphorylate RNA pol II, promoting transcription elongation https://t.co/JS8izirLmC